loading page

INTERLEUKIN 6 AS A MARKER OF SEVERE BACTERIAL INFECTION IN CHILDREN WITH SICKLE CELL DISEASE AND FEVER
  • +9
  • Elena Rincon-Lopez,
  • Maria Navarro Gómez,
  • Teresa Hernández-Sampelayo Matos,
  • David Aguilera-Alonso,
  • Eva Dueñas-Moreno,
  • Jesús Saavedra-Lozano,
  • Begoña Santiago-Garcia,
  • Maria Del Mar Santos,
  • Marina García-Morin,
  • Cristina Beléndez,
  • Jorge Lorente-Romero,
  • ELENA CELA
Elena Rincon-Lopez
Hospital General Universitario Gregorio Maranon

Corresponding Author:[email protected]

Author Profile
Maria Navarro Gómez
Hospital General Universitario Gregorio Maranon
Author Profile
Teresa Hernández-Sampelayo Matos
Hospital General Universitario Gregorio Maranon
Author Profile
David Aguilera-Alonso
Hospital General Universitario Gregorio Maranon
Author Profile
Eva Dueñas-Moreno
Hospital General Universitario Gregorio Marañón
Author Profile
Jesús Saavedra-Lozano
Hospital General Universitario Gregorio Maranon
Author Profile
Begoña Santiago-Garcia
Hospital General Universitario Gregorio Maranon
Author Profile
Maria Del Mar Santos
Hospital General Universitario Gregorio Marañón
Author Profile
Marina García-Morin
Hospital General Universitario Gregorio Maranon
Author Profile
Cristina Beléndez
Hospital General Universitario Gregorio Maranon
Author Profile
Jorge Lorente-Romero
Hospital General Universitario Gregorio Marañón
Author Profile
ELENA CELA
Hospital General Universitario Gregorio Maranon
Author Profile

Abstract

Introduction Etiological diagnosis of fever in sickle cell disease (SCD) children is often challenging. Objective: to analyze the pattern of inflammatory biomarkers in SCD febrile children and controls, in order to determine predictors of severe bacterial infection (SBI). Methods Prospective, case-control study of febrile and steady-state SCD children carried out during 3 years. Clinical characteristics and laboratory parameters, including 10 serum proinflammatory cytokines (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-17a, IFN-γ and TNF-α) and comparisons among study subgroups were analyzed. Results A total of 137 patients (78 cases and 59 controls) were included in the study; 78.5% males, median age 4.1 (1.7-7.5) years. Four cases were diagnosed with SBI, 41 viral infection (VI) and 33 no proven infection (NPI). IL-6 was significantly higher in patients with SBI than in patients with VI or NPI (163 vs 0.7 vs 0.7 pg/ml, p < 0.001), and undetectable in all controls. The rest of the cytokines analyzed did not show any significant difference. The optimal cut-off value of IL-6 for the diagnosis of SBI was 125 pg/mL, with high PPV and NPV (PPV of 100% for a prevalence of 5, 10 and 15% and NPV of 98.7%, 97.3% and 95.8% for those prevalences, respectively). Conclusion We found that IL-6 (optimal cut-off value of 125 pg/ml) was a very good marker for SBI in this cohort of febrile SCD children, with high PPV and NPV. Therefore, IL-6 may be useful, alone or combined with other biomarkers, to guide the management of these patients.